The interaction between RUNX2 and core binding factor beta (CBFβ) as a potential therapeutic target in canine osteosarcoma

Osteosarcoma remains the most common primary bone tumor in dogs with half of affected dogs unable to survive one year beyond diagnosis. New therapeutic options are needed to improve outcomes for this disease. Recent investigations into potential therapeutic targets have focused on cell surface molec...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vet Comp Oncol
Egile Nagusiak: Alegre, Fernando, Ormonde, Amanda R., Godinez, Dayn R., Illendula, Anuradha, Bushweller, John H., Wittenburg, Luke A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7233265/
https://ncbi.nlm.nih.gov/pubmed/31381810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12526
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak